STOCK TITAN

Perceptive Advisors (NASDAQ: ENGN) discloses 9.99% beneficial stake with warrant cap

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. report beneficial ownership of enGene Holdings Inc. common shares. Based on 66,989,466 Common Shares outstanding as of June 9, 2026, each Reporting Person is deemed to beneficially own 6,899,803 Common Shares, or 9.99% of the class. The Master Fund directly holds 4,822,169 Common Shares and 2,735,295 Pre-Funded Warrants exercisable at $0.0001 per share, but a 9.99% Beneficial Ownership Limitation currently allows exercise for only 2,077,634 Common Shares; the remaining warrants are treated as not exercisable for reporting purposes. Voting and dispositive power over these securities is shared among the Reporting Persons.

Positive

  • None.

Negative

  • None.
Shares outstanding 66,989,466 Common Shares Common Shares outstanding as of June 9, 2026
Beneficial ownership 6,899,803 Common Shares Beneficially owned by each Reporting Person
Ownership percentage 9.99% Percent of enGene Common Shares owned by each Reporting Person
Direct common shares held 4,822,169 Common Shares Common Shares directly held by the Master Fund
Total pre-funded warrants 2,735,295 Pre-Funded Warrants Pre-Funded Warrants held by the Master Fund
Currently exercisable warrants 2,077,634 Common Shares Common Shares issuable on exercise within the Beneficial Ownership Limitation
Warrant exercise price $0.0001 per share Exercise price of the Pre-Funded Warrants for Common Shares
Pre-Funded Warrants financial
"The Master Fund directly holds 4,822,169 Common Shares and 2,735,295 Pre-Funded Warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation (as defined below)"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
beneficially own regulatory
"the Reporting Persons would beneficially own, as determined in accordance with Section 13(d)"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared dispositive power financial
"Shared Dispositive Power 6,899,803.00"
shared voting power financial
"Shared Voting Power 6,899,803.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

FAQ

What percentage of enGene Holdings Inc. (ENGN) does Perceptive Advisors report owning?

Perceptive Advisors, Joseph Edelman, and the Master Fund each report beneficial ownership of 9.99% of enGene’s Common Shares. This is based on 66,989,466 shares outstanding as of June 9, 2026, including certain exercisable Pre-Funded Warrants.

How many enGene (ENGN) shares are beneficially owned by the Perceptive entities?

The Reporting Persons disclose beneficial ownership of 6,899,803 Common Shares of enGene. This total includes directly held shares and Pre-Funded Warrants that are currently exercisable within the 9.99% Beneficial Ownership Limitation.

What enGene (ENGN) securities does Perceptive Life Sciences Master Fund directly hold?

The Master Fund directly holds 4,822,169 Common Shares and 2,735,295 Pre-Funded Warrants of enGene. The warrants are immediately exercisable for Common Shares at an exercise price of $0.0001 per share, subject to the Beneficial Ownership Limitation.

How does the 9.99% Beneficial Ownership Limitation affect Perceptive’s ENGN warrants?

The Beneficial Ownership Limitation restricts the Reporting Persons from exceeding 9.99% ownership after warrant exercise. As of this report, it permits exercise of Pre-Funded Warrants for up to 2,077,634 Common Shares, with remaining warrants assumed not exercisable for reporting.

Who has voting and dispositive power over the reported enGene (ENGN) shares?

Perceptive Advisors, Joseph Edelman, and the Master Fund each report 0 sole voting or dispositive power and 6,899,803 shared voting and shared dispositive power. Perceptive Advisors manages the Master Fund, and Joseph Edelman is Perceptive Advisors’ managing member.

What share count did enGene (ENGN) report outstanding for this ownership calculation?

The ownership percentages are calculated using 66,989,466 Common Shares outstanding as of June 9, 2026. This figure comes from enGene’s Quarterly Report on Form 10-Q filed on June 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





29286M105

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:08/14/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:08/14/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:08/14/2026